School of Medicine
Showing 1-9 of 9 Results
-
Dhriti Nagar
Postdoctoral Scholar, Neonatal and Developmental Medicine
BioPremature birth is a leading cause of developmental and neuropsychiatric disorders in children. One of the factors causing these defects is lowered levels of available oxygen (hypoxia) in the newborn due to immature lungs. My research focuses on understanding the cellular and molecular mechanisms underlying hypoxia-induced developmental disorders of the nervous system due to preterm birth.
-
Michitaka Nakano
Basic Life Research Scientist, Medicine - Med/Hematology
BioI am a MD/PhD postdoctoral fellow and medical oncologist with a long-standing interest in translational cancer research. My long-term goal is to be a lab-based physician-scientist and independent academic researcher, translating basic cancer research, and mentoring next-generation scientists. My thesis work in Japan focused on cancer stem cell equilibrium by uniquely applying organoid culture as a method to elucidate cancer stem cell dynamics, which was awarded in Japanese Cancer Association. Along with the development of the field represented by success in T cell checkpoint, my interest gradually shifted to immune oncology while I examined numerous numbers of cancer patients as a medical oncology fellow. My postdoctoral fellowship at Calvin Kuo Lab in Stanford (2019-present) focuses on tumor immune microenvironment. Kuo lab developed a unique 3D air-liquid interface (ALI) organoid system that cultures tumors while preserving their endogenous infiltrating immune cells (T,B ,NK, Myeloid cells). My postdoctoral work will prove the significance of organoids as a translational tool to discover tumor-immune interaction by novel checkpoint inhibitors for immune cells, which can be broadly applicable to basic cancer biology, precision medicine, therapeutics validation and biomarker discovery.
-
Kerem Nernekli
Temp - Non-Exempt, Rad/Pediatric Radiology
BioDr. Nernekli has a wide-ranging research background encompassing molecular imaging, surgical neuroanatomy, clinical outcome studies, and machine learning, focusing on medical image reconstruction and multimodal deep learning algorithms for classification and segmentation tasks. Currently, he is focused on investigating novel radiotracer and activatable Gd-based contrast agents to detect senescence in large animal models with PET/MRI. Furthermore, Dr. Nernekli is exploring the potential of ferumoxytol-MRI and two-photon microscopy to correlate theranostic nanoparticles in their natural environment in order to gain a deeper understanding of their interactions with tumor-associated microenvironments.
-
Kouta Niizuma
Basic Life Research Scientist, Stem Cell Bio Regenerative Med Institute
BioI am a Research Scientist in Prof. Hiromitsu Nakauchi's laboratory at Stanford University. I obtained my PhD in Immunology from the University of Tsukuba, Japan. During my doctoral studies in Prof. Akira Shibuya's laboratory, I focused on the characterization of cell surface receptors expressed on immune cells. I successfully cloned a novel human immunoglobulin-like receptor, CD300H, and established a specific monoclonal antibody. My research demonstrated that CD300H is expressed on a subset of human monocytes and dendritic cells and plays a crucial role in enhancing inflammation by promoting the production of inflammatory cytokines and chemokines.
During my PhD, I also studied as a visiting scholar in Prof. Lewis L. Lanier's laboratory at UCSF, where I investigated the role of the activating receptor NKG2D on NK cells in viral immunity.
Since May 2018, I have been a member of the Nakauchi lab. My current research focuses on the development of new immunotherapies using myeloid cells derived from iPS cells, the generation of monoclonal antibodies, and hematopoietic stem cell biology. -
Margaret Claire Nikolov
Senior Manager of Quantitative Analysis, Clinical Excellence Research Center (CERC) Operations
BioDr. Meg Nikolov joined CERC in July 2022 as Senior Manager of Quantitative Analysis. Prior to CERC, Meg led the Technical Consulting and Advanced Analytics team, National Market Research at Kaiser Permanente, where her work focused on access to care and on telehealth during the COVID-19 pandemic. Prior to relocating to the West Coast, Meg was Assistant Professor in the Math Department at the United States Naval Academy. At the Naval Academy, Meg coordinated and taught the statistics and probability courses, co-taught the capstone research course in quantitative economics, advised student research projects, and collaborated with faculty on interdisciplinary research. Meg continues to collaborate on research exploring gender and racial bias in professional performance evaluations. Meg received her Bachelor of Science in Statistics and Biometry from Cornell University and her PhD in Biostatistics from Harvard T.H. Chan School of Public Health.